T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission | Zendy

Lauren Elreda | Zendy; Manpreet Sandhu | Zendy; Xinlai Sun | Zendy; Wondwessen Bekele | Zendy; Alice J. Cohen | Zendy; Maya Shah | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

T-Cell Lymphoblastic Leukemia/Lymphoma: Relapse 16 Years after First Remission

Author(s) -

Lauren Elreda,

Manpreet Sandhu,

Xinlai Sun,

Wondwessen Bekele,

Alice J. Cohen,

Maya Shah

Publication year - 2014

Publication title -

case reports in hematology

Language(s) - English

Resource type - Journals

eISSN - 2090-6560

pISSN - 2090-6579

DOI - 10.1155/2014/359158

Subject(s) - medicine , complete remission , lymphoblastic leukemia , lymphoblastic lymphoma , lymphoma , pediatrics , disease , spontaneous remission , complete response , leukemia , overall survival , cure rate , oncology , chemotherapy , immunology , t cell , pathology , alternative medicine , immune system

Little information is available regarding late relapse in patients with T-lymphoblastic leukemia/lymphoma (T-LBL). Because of the aggressive nature of this disease, relapse is common and often happens early. Late relapses are rare and generally occur within a few years after initial remission. The relapse rate after 3 years has been reported to steadily decrease over time yet does not parallel with cure. We report a case of a 26-year-old female with T-LBL and relapse 16 years after her first remission with successful treatment with HyperCVAD and L-asparaginase.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research